EUVIMEDEUVIMED entdecken
Querschnittstudie

Self-reported implant-site inflammatory reactions after COVID-19 vaccination among Indonesian cosmetic implant recipients: Cross-sectional survey

Ago Harlim, Hulman Panjaitan, Hubert Andrew, Chastine Harlim

Journal of Pharmacy & Pharmacognosy Research · 01.07.2026 · 14 (4) · 2722

DOI: 10.56499/jppres_14.4.2722 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Pharmacy & Pharmacognosy Research, online erschienen am 01.07.2026. Verfasst von Ago Harlim und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Delayed inflammatory reactions at cosmetic implant sites have been reported after coronavirus disease 2019 vaccination, but population-level data from Indonesia remain limited.

Aims

To estimate the prevalence of self-reported implant-site inflammatory reactions after coronavirus disease 2019 vaccination among cosmetic implant users in Indonesia and to explore associated factors.

Methods

A cross-sectional online survey was distributed in Indonesia from November 2021 to July 2022. Respondents receiving at least one coronavirus disease 2019 vaccine dose who reported having a cosmetic implant were included. The primary outcome was self-reported localized redness, swelling, or pain at the implant site rather than clinically verified foreign-body reaction.

Results

Among 1,610 valid responses, 266 respondents reported having cosmetic implants. Implant-site inflammatory reactions were reported by 10 respondents, corresponding to a period prevalence of 3.76% (95% CI: 1.82–6.80%). Adverse vaccine reactions were reported by 91 respondents (34.2%). An exploratory analysis suggested these respondents had higher odds of implant-site inflammatory reactions (OR: 4.78; 95% CI: 1.21–18.94; p = 0.04). However, this finding must be interpreted cautiously because only 10 events were observed and multivariable adjustment was not possible. No significant association was observed with age, sex, or vaccine type.

Conclusions

A small proportion of respondents with cosmetic implants reported implant-site inflammatory symptoms following coronavirus disease 2019 vaccination. Because outcomes were self-reported, derived from a cross-sectional design, and key confounders were unmeasured, causal interpretation remains uncertain. These findings should be interpreted strictly as hypothesis-generating pharmacovigilance evidence. Prospective, clinically validated studies incorporating detailed implant characterization and reaction timing are required.

Zitieren

APA

Harlim, A., Panjaitan, H., Andrew, H., & Harlim, C. (2026). Self-reported implant-site inflammatory reactions after COVID-19 vaccination among Indonesian cosmetic implant recipients: Cross-sectional survey. Journal of Pharmacy & Pharmacognosy Research, 14(4), 2722. https://doi.org/10.56499/jppres_14.4.2722

Vancouver

Harlim A, Panjaitan H, Andrew H, Harlim C. Self-reported implant-site inflammatory reactions after COVID-19 vaccination among Indonesian cosmetic implant recipients: Cross-sectional survey. Journal of Pharmacy & Pharmacognosy Research. 2026;14(4):2722. doi:10.56499/jppres_14.4.2722

BibTeX
@article{Harlim2026,
  author = {Harlim, Ago and Panjaitan, Hulman and Andrew, Hubert and Harlim, Chastine},
  title = {Self-reported implant-site inflammatory reactions after COVID-19 vaccination among Indonesian cosmetic implant recipients: Cross-sectional survey},
  journal = {Journal of Pharmacy & Pharmacognosy Research},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {2722},
  doi = {10.56499/jppres_14.4.2722}
}
Kostenlos starten →